Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently AU$54.87M. The company's EPS TTM is AU$-0.01; its P/E ratio is 21.34; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24
Jun 23
Jun 22
Jun 21
Jun 20
Currency in AUD
Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History
